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Background: Infectious bronchitis virus (IBV) is a Gammacoronavirus of the family Coronaviridae and is a causative
agent of an economically important disease in poultry. The spike glycoprotein of IBV is essential for host cell
attachment, neutralization, and is involved in the induction of protective immunity. Previously obtained sequence
data of the spike gene of IBV QX-like and Massachusetts strains were subjected to bioinformatics analysis.
Findings: On analysis of potential phosphorylation sites, the Ser542 and Ser563 sites were not present in
Massachusetts strains, while QX-like isolates did not have the Ser534 site. Massachusetts and QX-like strains showed
different cleavage site motifs. The N-glycosylation sites ASN-XAA-SER/THR-55, 147, 200 and 545 were additionally
present in QX-like strains. The leucine-rich repeat regions in Massachusetts strains consisted of stretches of 63 to 69
amino acids, while in the QX-like strains they contained 59 amino acids in length. An additional palmitoylation site
was observed in CK/SWE/082066/2010 a QX-like strain. Primary structure data showed difference in the physical
properties and hydrophobic nature of both genotypes. The comparison of secondary structures revealed no new
structural domains in the genotypic variants. The phylogenetic analyses based on avian and mammalian
coronaviruses showed the analysed IBV as closely related to turkey coronaviruses and distantly related to thrush
and munia coronaviruses.
Conclusion: The study demonstrated that spike glycoprotein of the Massachusetts and the QX-like variants of IBV
are molecularly distinct and that this may reflect in differences in the behavior of these viruses in vivo.
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Infectious bronchitis virus (IBV) causes avian infectious
bronchitis, a highly contagious disease that affects poultry
and produces severe economic losses worldwide. IBV
belongs to the order of Nidovirales, family Coronaviridae
and to genus of Gamma-coronavirus group 3 [1]. The gen-
ome is positive-sense single stranded RNA of about
27.6 kb and contains 5′ and 3′ untranslated regions [2-4].
The Massachusetts strain was initially isolated in 1940
in USA and clinically characterized as causing respiratory
signs and decrease in egg production. It is widely* Correspondence: Shahid.hussein.abro@sva.se
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reproduction in any medium, provided the ordistributed and predominant in many countries around
the world [5]. The Massachusetts strain can infect differ-
ent organs and some of the isolates could be recovered
from gastrointestinal tract especially from the cecal tonsils
[6,7]. First IBV QX infections characterized by swelling of
stomach in chicken flocks were reported in Qingdao
China in 1996 [8]. Following the years the IBV QX viral
infections was associated to either proventriculitis or renal
infections in IBV vaccinated flocks in China [9,10]. The
decreases in egg production and false layers in mature
hens in chicken flocks were also reported with QX infec-
tions [10,11]. Later on Chinese QX of IBV was isolated
from a backyard flock in Russia where the prevalence of
Chinese QX-like genotype was common [12,13]. Subse-
quently there have been increasing reports of QX-like
cases in Europe, where the involved virus bearded
sequence similarities to QX-like viruses, such as the casesd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Netherlands, Poland, Russia, Slovenia, Spain, Sweden, and
UK [7,14-19]. These IBV viruses were termed as European
QX-like viruses symptoms associated with bad egg quality,
false layers in mature hens [2].
The spike glycoprotein of the virus is translated as a
pre-cursor protein (SO) that is later cleaved into the
N-terminal S1 and C-terminal S2 glycopolypeptides. The
spike gene is highly variable, especially the S1 part, due
to insertions, deletions, substitutions and recombination
events [14,20,21]. The S1 part of the spike glycoprotein
contains serotype specific virus neutralizing epitopes and
is responsible for the hemagglutinating activity and for
infectivity [22]. Due to this variability in nucleotide
sequences, the cross protection between serotypes is
low. Changes as little as 5% in the S1 sub-unit have been
able to alter the protection ability of a vaccine [23]. The
spike glycoprotein cleavage site motif has been described
in bovine coronavirus, turkey coronavirus and human
coronavirus, however, it is not found in all coronaviruses
[24]. The cleavage recognition site in the spike glycopro-
tein of IBV consists of five basic amino acids, which is
cleaved by host cell serine proteases [25]. Serine pro-
teases are hydrolases that cleave peptide bonds [26,27].
The cleavage recognition site sequence is not involved in
pathogenicity because attenuated and pathogenic strains
(same virus) possess identical cleavage recognition site
sequences [26]. The spike glycoprotein of IBV is involved
in induction of protective immunity, neutralization and at-
tachment to the host cell [28,29]. It contains crucial virus
neutralizing epitopes and serotypic specific sequences that
are involved in, induction of protective immunity, tissue
tropism and attachment into host cells [22,25,30-32].
Palmitoylation is essential for the screening, localization
and trafficking at sub-cellular level, protein-protein inter-
actions, and to pre-determine functional properties of
proteins [33,34]. N-glycosylation properties of the glyco-
protein were shown to be involved in changes of virulence
and cellular tropism in lactate dehydrogenase-elevating
virus [35]. Protein phosphorylation has key role in regula-
tion of physiological functions in the cells of prokaryotes
and eukaryotes [36]. Leucine-rich repeat (LRR) is a struc-
tural motif of the protein like a alpha/beta horseshoe fold
which is relevant for protein-protein interactions [37,38].
In this study, palmitoylation, leucine-rich repeat and N-
glycosylation characteristics of IBV Massachusetts and
QX-like strains were evaluated using bioinformatics tools
in order to determine the extent of difference in structural
and functional features between the strains.
The objective of the present study was to analyze the
molecular characteristics of selected isolates belonging
to classical (Massachusetts) and emerging (QX-like)
genotypes of IBV to indentify differences in potential
functional motifs of the spike glycoprotein, predicted bybioinformatics analysis. In addition an evolution analysis




The loss or acquisitions of N-glycosylation sites in the
spike protein were predicted. Thirty N-glycosylation
sites were found in the Massachusetts strains, while
35 N-glycosylation sites were present in the QX-like
strains. The N-glycosylation sites ASN-XAA-SER/THR-
55, 147, 200 and 545 were additionally present in spike
gene of QX-like strains. The results revealed that most
of the N-glycosylation sites were conserved within geno-
type in the analyzed strains, except in strain CK/SWE/
082066/10 that had lost ASN-XAA-SER/THR-533.
Analysis of potential phosphorylation sites
The analyses revealed that there were different in number
and location of potential phosphorlated peptides in the
spike glycoprotein. In Massachusetts isolates phosphoryl-
ation sites at position Ser54, Ser79, Ser312, Ser404,
Ser534, Ser618, Ser685, Ser908 and Ser1061 were found to
be conserved. While two isolates CK/SWE/242/95 and
CK/SWE/748/95 that did not contain phosphorylation
sites at position Ser542 and Ser563. In contrast, they con-
tained additional potential phosphorylation sites at Ser177
and Ser878. QX-like strains did not contain a potential
phosphorylation site at position Ser534 and acquired a
new potential phosphorylation site at position Ser513.
Proteolytic cleavage sites in the spike glycoprotein
The cleavage site motifs of analyzed strains are pre-
sented in Table 1. Massachusetts and QX-like strains
showed a different cleavage site motif. From the ana-
lyzed strains of both genotypes, six strains have shown
the cleavage site at amino acid position 537 arginine,
while two strains CK/SWE/242/95 and CK/SWE/748/95
presented cleavage site at histidine.
Determination of leucine-rich repeat regions
Leucine-rich repeat (LRR) regions were observed in the
spike glycoprotein consisting of 59 to 69 amino acids in
length. In isolate CK/SWE/748/95 two LRR regions were
found, starting at position at 771 (ATQLQARNNAL)
and 1147 (LEKLSILKTYI), respectively. The LRR regions
in Massachusetts strains consisted of stretches of 63 to
69 amino acids, while in the QX-like strains they con-
tained 59 amino acids in length.
Prediction of palmitoylation sites
The isolates CK/SWE/748/95, CK/SWE/1096/97 and
CK/SWE/062545/09 contained 10 palmitoylation sites in
the spike glycoprotein of the virus. The isolate CK/
Table 1 Cleavge site motif in Swedish IBV strains
Strian Type Cleavage site sequence
motif
CK/SWE/242/95 Massachusetts 535Aln-Gly-His-Ser-Ile539
CK/SWE/748/95 Massachusetts 535 Aln-Gly-His-Ser-Ile539
CK/SWE/423/97 Massachusetts 535 Leu-Arg-Arg-Ser-Ile539
CK/SWE/1096/97 Massachusetts 535 Leu-Arg-Arg-Ser-Ile539
CK/SWE/062545/09 QX-like 535 Ser-His-Arg-Thr-Arg539
CK/SWE/062561/09 QX-like 535 Ser-His-Arg-Thr-Arg539
CK/SWE/079692/10 QX-like 535 Ser-Gln-Arg-Arg-Arg539
CK/SWE/082066/10 QX-like 535 Ser-Gln-Arg-Arg-Arg539
Cleavage site at amino acid position 537 =
Amino acid abbreviations: Aln = alanine, Gly = glycine, His = histidine, Ser =
serine.
Ile = Isoleucine, Thr = threonine, Arg = arginine, Gln = glutamine.
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site 1130 (CGGCFGI) in comparison to the all other
analyzed isolates.
Primary structure of the spike glycoprotein
The data regarding the primary structures are presented
in (Additional file 1: Table S1). The strains of Massachu-
setts group were found to have differences of approxi-
mately 0.3-1.2 KDa in their molecular weights, while
QX-like strains possessed similar molecular weight. The
isoelectric points (pI) 5.63-6.72 of the Massachusetts
strains were comparatively higher than pI 5.73 of QX-
like strains. There were 82-87 positively charged residues
(Arg + Lys) in the QX-like strains, 2-4 residues more
than Massachusetts strains. The computed instability
index and aliphatic index (AI) showed variable values
(83.79-85.91) in all analyzed strains. The grand hydro-
pathicity (GRAVY) was found to have negative values in
all strains. The primary structure data showed difference
in the hydrophobic nature of both genotypes. The pri-
mary structures of the spike glycoprotein were found to
be relatively variable in the strains.
Prediction of secondary structures of spike glycoproteins
The data regarding the secondary structures are pre-
sented in (Additional file 2: Table S2). All the analyzed
isolates contained 18 to 19 alpha helices, 47-58 beta
sheets and 63-73 residual coils. In the case of alpha heli-
ces and beta sheets, there was additionally one alpha
helix and 11 beta strands in Massachusetts strains than
in QX-like strains.
Phylogenetic analysis
The phylogenetic analysis of the complete spike gene
based on avian coronaviruses revealed the sequences of
the analysed strains segregated into three main groups
(Figure 1). Group I was composed of IBV sequences that
clustered together with those of Massachusetts,Arkansas and QX-like genotypes, as previously described
by Abro et al. (2012) [14]. The definition of those geno-
types is supported by high bootstrap values of 100%.
Group II consisted of turkey coronaviruses branching
closely to the IBV. Group III consisted of sequences of
munia and thrush coronaviruses, branching into two
clusters: one comprising munia coronaviruses and the
other thrush coronaviruses. The high bootstrap values
(100%) indicate a true distance between these clusters
and that they are likely species-specific.
The phylogenetic analysis based on the spike glycoprotein
of avian and mammalian coronaviruses strains has shown
as the following discrimination (Figure 2): a) Sequences of
IBV and turkey coronaviruses making the majority of avian
coronaviruses. The sequences of Beluga whale corona-
viruses and one bat-coronavirus HKU2 were distantly
related to this branch of avian sequences, altogather com-
posing the gama-coronaviruses. b) A set of sequences com-
prising separate clusters of avian, bat, human and feline
coronaviruses, thus including both avian and mammalian
coronaviruses. c) A set of strictly mammalian corona-
viruses, branching into the SARS, human coronavirus
HKU1, bat coronaviruses and a cluster majorly of animal
coronaviruses comprising murine, equine, porcine and bo-
vine coronaviruses. The sequence of human coronavirus
OC43 was found in this cluster, curiously identical to a cor-
onavirus identified in pigs and closely related to bovine
coronaviruses. Porcine hemagglutinating encephalomyelitis
virus occupied a distinct place between the human and
equine coronaviruses clusters.
Discussion
A genetic analysis of the complete spike glycoprotein of
selected isolates of Massachustes and QX-like strains
was carried out in order to predict molecular features by
application of molecular and In silico technologies.
In the isolate CK/SWE/082066/10, amino acid phenyl-
alanine substituted asparagine resulting in the loss of a
potential N-glycosylation site at position 533. The five
additional N-glycosylation sites found in QX strains may
influence cellular tropism. The variation in N-glycosylation
sites may affect survival and transnsmission of the virus.
The small changes can lead to disturbance in folding and
conformation of the molecule. The variations in N-
glycosylation sites may affect the interaction with receptors
and render a virus more susceptible to host innate immune
system and lower recognition by antibody, hence affecting
the virus replication and infectivity [39-42]. In a virus
belonging to the Coronaviridae, lactate dehydrogenase
elevating virus (LDEV), the loss or acquisition of N-
glycosylation sites in the protein has been reported to de-
termine changes of virulence and cellular tropism [35].
The presence of serine, threonine and tyrosine residues,
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Figure 1 Phylogenetic analysis based on complete spike gene of avian coronaviruses showing the relationship between IBV and avian
coronaviruses. The isolates analysed in this study are indicated by square.
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Figure 2 (See legend on next page.)
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Figure 2 Phylogenetic analysis based on complete spike gene of avian and mammalian coronaviruses showing the relationship
between coronaviruses in different host species.
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shown that the spike glycoprotein of IBV genotypes con-
tained serine and thereonine peptides with potential for
phosphorylation. The substitution of a serine by amino
acid alanine at positions 563 caused loss of a potential
phosphorylated peptide in strains CK/SWE/242/95 and
CK/SWE/748/95. Wilbur et al. (1986) reported that N
protein is the only structural protein that contained phos-
phorylation activity in coronaviruses [43]. In this context
we have observed potential phosphorylated peptides in the
spike glycoprotein of IBV; however, this seems to be of no
consequence for phosphorylation, since this property has
not been identified in the spike which is well established
as a glycoprotein.
The difference in cleavage site motifs of the spike glyco-
protein of both genotypes, seem to indicate a correlation
with geographical distribution of strains. It has been
reported that serotypically and genotypically different IBV
contain distinct cleavage site in the spike protein. How-
ever, the cleavage site sequence did not correlate with
pathogenicity by comparing cleavage recognition sites in
pathogenic and attenuated strains of IBV [26]. The cleav-
age site motifs determined in Massachusetts and QX-like
strains in present study are different from previously
reported by Jackwood et al. (2001) [26]. The replacement
of arginine with histidine at amino acid position 537 in
CK/SWE/748/95 and CK/SWE/748/95 may have influ-
ence antibody binding epitope. However, the functional
meaning of this difference needs to be evaluated in proper
biological assays. It has been reported that an IBV mono-
clonal antibody neutralization-resistant mutant (NR 18)
had shown substitution of amino acid isoluecine for argin-
ine in cleavage site motif which prevented cleavage and
alter the conformation dependent monoclonal antibody
binding epitope [26]. In orthomyxoviruses and paramyxo-
viruses more basic residues around the cleavage recogni-
tion site of the envelope glycoproteins enhance the
cleavability by ubiquitous host cell proteases, a character-
istic which is associated with host cell range and increased
virulence [44,45]. However, the relevance of cleavage site
to virulence was not observed in case of IBV spike glyco-
protein [26].
The data regarding leucine-rich repeat regions of
isolate CK/SWE/748/95 demonstrated that two LRR
regions may result in strong folding capacity in the spike
glycoprotein. It has been reported that leucine-rich re-
peat (LRR) is a structural motif of protein like a alpha/
beta horseshoe fold and is responsible for protein-
protein interactions [37,38].An additional palmitoylation site was found only in
isolate CK/SWE/082066/10, indicating that it is strain
specific. However, experimental studies are required to
identify the effect of additional palmitoylation in the
virus biology. In influenza virus, palmitoylation of the
cytoplasmic domain of the hemagglutinin has been
shown to increase its association with lipid mass [46].
The deletion of palmitoylation sites in the hemagglutinin
domain reduces hemagglutinin incorporation into the
virion, thereby affecting the cellular trafficking [47]. It
has been reported that removal of palmitoylation sites in
HIV-1 virus effected in the formation of virus with low
levels of glycoproteins incorporation and reduced infect-
ivity [48]. Shen et al. (2009) reported attenuation of virus
replication occurring due to mutations in the palmitoy-
lation site in the non-structural protein nsp1 of Semliki
Forest virus [49].
The predicted primary structures of the spike glyco-
protein of both genotypic variants have shown a variable
trend in physical properties such as isoelectric point,
molecular weights and grand hydropathicity index.
Grand average of hydropathicity index results suggested
a hydrophobic nature of the spike glycoprotein in all
variants. Cavanagh et al. (1986) reported that S2 sub-
unit in N-terminal side of the membrane spanning
hydrophobic domain of spike glycoprotein of IBV is sus-
ceptible to hydrolysis by many proteases [32].
The secondary structures prediction revealed that
structures of the spike glycoprotein were found variable
in both genotypic variants. It was also observed that
there were no new structural domains and that no evo-
lution has occurred in the structure of both genotypic
variants. However, secondary structural variation in beta
strands and residual coils have been observed between
both genotypic strains.
A number of phylogenetic studies performed on the
spike gene were mostly based on the partial sequences
of S1 and N gene. Phylogenetic analyses based on the
complete spike glycoprotein of avian coronaviruses
demonstrated that IBV strains showed higher relatedness
to turkey coronaviruses in comparison to other avian
coronaviruses (Figure 1). This could be due to co-
habitation of their host species. The appearance of a bat
coronavirus branch close to these gammacoronaviruses
suggests a possible common origin during earlier evolu-
tion of these viruses. The diversity of these viruses could
have arisen from strong selective pressure resulting from
mutations and recombinations that has been shown to
occur in spike gene [14,50,51].
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coronaviruses and mammalian coronaviruses had revealed
interesting trends. The mammalian beluga whale corona-
viruses branched closer to the avian coronaviruses and two
avian thrush and munia coronaviruses were related to the
mammalian coronaviruses suggesting interspecies transmis-
sion. Furthermore, findings of the present study suggest
that genetic diversity and molecular variation in sequences
of spike glycoprotein of viruses made feasible the adapta-
tion to new host species. Previously it has been reported
that the RNA-dependant RNA polymerase gene and the
whole genome of the beluga whale coronavirus was dis-
tantly related to IBV [52,53]. Also a shift of tissue tropism
in the virus has been reported [54,55] resulting in infection
of a wide range of avian host species especially those reared
close to domestic fowl. For example, IBV cases were found
in guinea fowl (Numida meleagris), Chinese peafowl (Pavo),
teal (Anas) and partridge (Alectoris) [56].
The higher diversity in the avian, humans and bat-
coronaviruses are due to continuous mutation, which may
determine differences in tissue tropism. Previously it has
been reported that diversity of coronaviruses due to a) infi-
delity of RNA-dependant RNA polymerase which lead to
incorporation of nucleotide errors during replication
[34,57]; b) random template switching during RNA replica-
tion (copy choice mechanism) high rate of homologous
RNA recombination events [4,58]; c) extra plasticity nature
in adjusting and modifying genes [59]. These factors were
responsible for the generation and diversification of variants
and adaption to new hosts and ecological niches in the cor-
onaviruses [53,59].
Conclusions
In silico predictions confirm previous data on phylogen-
etic analysis, showing that the spike glycoprotein of the
Massachusetts and QX genotypes are molecularly differ-
ent. Since the spike glycoprotein has important role in cell
attachment, receptor recognition, the genetic diversity
seen in this protein of IBV, avian, human, bat, and other
animal coronaviruses may bear relation with host specifi-
city. The identification of these characteristics will be
foundation for the better understanding of epidemics, mo-
lecular mechanisms of infections, evolution and basis for
development of effective vaccines. Bioinformatics ap-
proach is easy to perform, cheap and suitable to obtain
predictions about functional motifs in a genome. However,




The sequence data set generated as previously described
by Abro et al. (2012) [14] was used for the analysis
(Additional file 3: Table S3).Bioinformatics analysis
N-glycosylation sites were predicted by services available
on http://www.cbs.dtu.dk/services/NetNGlyc. The poten-
tial phosphorylation sites were determined by using web-
site http://www.cbs.dtu.dk/services/NetPhos. Leucine-rich
repeat regions were determined by LRRfinder available at
http://www.lrrfinder.com/result.php. Antigenic determi-
nants were predicted with the maximum score with the
high confidence for positive determinant motif in the
amino acid sequence with the help of server http://
mobyle.pasteur.fr. The primary structures of the spike
glycoprotein were predicted by http://expasy.org/tools.
Palmitoylation sites were predicted with the medium
threshold frequency by using services at http://csspalm.
biocuckoo.org/prediction.php. The secondary structures
(alpha helices, beta strands and random coils) of the pro-
tein were predicted by using bioinformatics tools available
on website http://npsa-pbil.ibcp.fr. The method of GOR4
http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=n-
psa_gor4.html was used to identify the alpha helices, beta
strands and coil residues. At least minimum three or more
turns were taken in account for one helix, strand or coil in
the structure of spike glycoprotein.
Phylogenetic analysis
The comprehensive phylogenetic study was carried out
based on the complete spike gene of avian and mamma-
lian coronaviruses available in GenBank. The sequences
included IBV Massachusetts type, M41, H120, Baudette,
Arkansas, QX like strains and other sequences of Turkey
coronavirus (TCoV), thrush coronavirus (ThCoV), munia
coronavirus (MuCoV), human coronavirus (HCoV), SARS
(Severe acute respiratory syndrome) coronavirus, bovine
coronavirus (BCoV), equine coronavirus (ECoV), mouse
hepatitis virus (MHV), murine coronavirus (MurCoV),
feline coronavirus (FCoV), porcine epidemic diarrhea virus
(PEDV), porcine respiratory coronavirus (PRCV), porcine
hamagglutinating encephalalomylitis virus (PHEV), bat
coronavirus and beluga whale coronavirus sequences
(Additional file 3: Table S3; Additional file 4: Table S4).
Multiple sequence alignment of complete spike gene was
performed with CLUSTAL W [60]. All the gaps in the
sequences created by insertions were deleted by using soft-
ware Mega4 version 4 [61]. Phylogenetic trees were con-
structed by the Neighbour-joining method with the
nucleotide substitution model of Kimura-2 parameter
model. The tree reliability/robuststness of the hypothesis
were evaluated by bootstrap of 1000 replicates. The data
set was kept similar for the analysis. The Bayesian analyses
were performed by using the software MrBayes 3.1 [62].
The model was set for the substitution rates lset nst = 6,
rates of variation were performed by gamma distribution
(rates = invgamma) posterior probability distribution
ensured and 2000000 generation were run and standard
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stitution model parameters were summarized with sump
burnin = 250. The tree topology was prepared in the
FigTree_v1.3.1. The trees were generated with various
methods and the consensus tree was taken into account in
this study.
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glycoprotein.
Additional file 2: Table S2. Predicted secondary structures of spike
glycoprotein.
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